Retatrutide and Skin: Evidence-Graded Look at Metabolic Load Reduction

(default writer prompt)

input: Write a data-first, evidence-graded article: Retatrutide for Skin
Slug: retatrutide-skin
Audience: readers researching peptide evidence for this specific condition or drug cross.
Rules: label every claim tier (human|preclinical|anecdotal|mechanistic|speculative). Separate human trials from rat studies from Reddit/X anecdotes. No medical claims. Repair-vs-suppression framing. register: source_ledger.

ENRICHMENT BRIEF (binding section logic — one ## per compound):
{"voice":"enrichment","article_shape":"single_focus","condition":null,"condition_key":null,"primary_peptide":null,"peptides_in_scope":[{"id":"retatrutide","name":"Retatrutide"}],"drugs_in_scope":[],"weight_sensitive":false,"stimulant_context":false,"breaking_down":{"section_title":"What's breaking down","degenerative_why":[],"dege

{
  "slug": "retatrutide-skin",
  "title": "Retatrutide and Skin: Evidence-Graded Look at Metabolic Load Reduction",
  "body": "## What's breaking down\n\nSkin health involves multiple layers that can degenerate when metabolic factors like excess body weight are present. Excess adipose tissue is linked to chronic low-grade inflammation and mechanical stretching of skin. Rapid changes in body composition can outpace the skin's ability to adapt its elasticity and structure. No direct skin degeneration profile is defined in the query, so layers are inferred from retatrutide's studied effects on body weight.\n\n## Why Retatrutide might help you\n\n1. **What keeps failing:** Excess body weight multiplies compressive load on spine, hips, knees, and plantar fascia.\n2. **What Retatrutide is studied to do:** Studied for GLP-1/GIP/glucagon-driven weight loss — less mechanical load, not direct disc regeneration.\n3. **Therefore for you:** If that layer is part of your problem, Retatrutide is discussed because it targets repair (metabolic load / body weight) — not because it masks pain.\n\nThe same weight-loss pathway may indirectly relate to skin by altering overall metabolic load, though trial data show skin sensations as a reported event rather than improvement.\n\n## How these fit together\n\nSingle-compound focus — if your condition profile includes a multi-peptide stack, siblings ta